Literature DB >> 33467122

Effective Isolation for Lung Carcinoma Cells Based on Immunomagnetic Separation in a Microfluidic Channel.

Hien Vu-Dinh1, Hui Feng2, Chun-Ping Jen1.   

Abstract

In this paper, we developed an isolation system for A549 human lung carcinoma cells as an effective factor for the early diagnosis of lung cancer. A microfluidic immunomagnetic method was used, in which the combination of immunomagnetic separation and a microfluidic system allowed for increased isolation efficiency with uncomplicated manipulation. In the microfluidic immunomagnetic strategy, A549 cells were combined with aptamer-conjugated carboxylated magnetic beads and then collected in a specified region by applying a magnetic field. The results were recorded using a fluorescence microscope, and the captured targets were then quantified. The isolation efficiency of A549 cells is up to 77.8%. This paper developed a simple working procedure, which is less time consuming, high-throughput, and trustworthy for the isolation of A549 cells. This procedure can be a useful reference method for the development of an effective diagnosis and treatment method for lung cancer in the future.

Entities:  

Keywords:  A549 cells; aptamer; immunomagnetic; lung cancer

Year:  2021        PMID: 33467122      PMCID: PMC7830457          DOI: 10.3390/bios11010023

Source DB:  PubMed          Journal:  Biosensors (Basel)        ISSN: 2079-6374


  27 in total

1.  Aptamers: problems, solutions and prospects.

Authors:  A V Lakhin; V Z Tarantul; L V Gening
Journal:  Acta Naturae       Date:  2013-10       Impact factor: 1.845

2.  A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells.

Authors:  M Lieber; B Smith; A Szakal; W Nelson-Rees; G Todaro
Journal:  Int J Cancer       Date:  1976-01-15       Impact factor: 7.396

Review 3.  Aptamer in bioanalytical applications.

Authors:  Anton B Iliuk; Lianghai Hu; W Andy Tao
Journal:  Anal Chem       Date:  2011-05-05       Impact factor: 6.986

4.  Aptamer-based microfluidic device for enrichment, sorting, and detection of multiple cancer cells.

Authors:  Ye Xu; Joseph A Phillips; Jilin Yan; Qingge Li; Z Hugh Fan; Weihong Tan
Journal:  Anal Chem       Date:  2009-09-01       Impact factor: 6.986

5.  Identification of CD90 as a marker for lung cancer stem cells in A549 and H446 cell lines.

Authors:  Xiuping Yan; Hu Luo; Xiangdong Zhou; Bingjing Zhu; Yuliang Wang; Xiuwu Bian
Journal:  Oncol Rep       Date:  2013-10-03       Impact factor: 3.906

6.  A simple point-of-care microfluidic immunomagnetic fluorescence assay for pathogens.

Authors:  Rui-Qiao Zhang; Shu-Lin Liu; Wei Zhao; Wan-Po Zhang; Xu Yu; Yong Li; An-Jun Li; Dai-Wen Pang; Zhi-Ling Zhang
Journal:  Anal Chem       Date:  2013-02-22       Impact factor: 6.986

Review 7.  Magnetic separation techniques in diagnostic microbiology.

Authors:  O Olsvik; T Popovic; E Skjerve; K S Cudjoe; E Hornes; J Ugelstad; M Uhlén
Journal:  Clin Microbiol Rev       Date:  1994-01       Impact factor: 26.132

8.  Paramagnetic Structures within a Microfluidic Channel for Enhanced Immunomagnetic Isolation and Surface Patterning of Cells.

Authors:  Chen Sun; Hamid Hassanisaber; Richard Yu; Sai Ma; Scott S Verbridge; Chang Lu
Journal:  Sci Rep       Date:  2016-07-08       Impact factor: 4.379

Review 9.  Magnetic Force-Based Microfluidic Techniques for Cellular and Tissue Bioengineering.

Authors:  Sena Yaman; Muge Anil-Inevi; Engin Ozcivici; H Cumhur Tekin
Journal:  Front Bioeng Biotechnol       Date:  2018-12-19

Review 10.  Microfluidics for studying metastatic patterns of lung cancer.

Authors:  Monika Ruzycka; Mihaela R Cimpan; Ivan Rios-Mondragon; Ireneusz P Grudzinski
Journal:  J Nanobiotechnology       Date:  2019-05-27       Impact factor: 10.435

View more
  1 in total

Review 1.  Integration of liquid biopsy and pharmacogenomics for precision therapy of EGFR mutant and resistant lung cancers.

Authors:  Jill Kolesar; Spencer Peh; Levin Thomas; Gayathri Baburaj; Nayonika Mukherjee; Raveena Kantamneni; Shirley Lewis; Ananth Pai; Karthik S Udupa; Naveena Kumar An; Vivek M Rangnekar; Mahadev Rao
Journal:  Mol Cancer       Date:  2022-02-24       Impact factor: 27.401

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.